{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:36:23Z","timestamp":1777934183540,"version":"3.51.4"},"reference-count":57,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2010,6,4]],"date-time":"2010-06-04T00:00:00Z","timestamp":1275609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:p>The treatment of leptomeningeal metastasis is based on protocols linking systemic chemotherapies and intrathecal injections of antineoplastic agents. Since the late 1960s, cases of accidental intrathecal injections of vinca-alkaloids, which have almost always proved fatal, have been documented. The most concerned countries, supported by the WHO, have published numerous recommendations aimed at reducing this type of risk. The aim of our work was to improve safety procedures for the intrathecal administration of antineoplastic drugs in an oncology hospital: the Centre Oscar Lambret, Lille, France. To this end, we compiled and analyzed a total of eight international recommendations. Our method was to meet the requirements of the AFSSAPS (French agency for the safety of health products), then to adopt recommended procedures in other countries, where appropriate.<\/jats:p>\n                  <jats:p>We considered the whole drugs circuit from prescription to administration. Improvements basically focused on the computerization of prescription, the dilution in mini-bags of vinca-alkaloids, and the additional labeling of intrathecally administered preparations as well as those with some vinca-alkaloids. This multidisciplinary approach to improve our practices complements the precautions taken by healthcare teams.<\/jats:p>","DOI":"10.1177\/1078155210372550","type":"journal-article","created":{"date-parts":[[2010,6,4]],"date-time":"2010-06-04T20:59:31Z","timestamp":1275685171000},"page":"252-259","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Securing the circuit of intrathecally administered cancer drugs: example of a collective approach"],"prefix":"10.1177","volume":"17","author":[{"given":"Guillaume","family":"Marliot","sequence":"first","affiliation":[{"name":"D\u00e9partement de Pharmacie Clinique, Centre Oscar Lambret, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Le Rhun","sequence":"additional","affiliation":[{"name":"D\u00e9partement de S\u00e9nologie, Centre Oscar Lambret, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilyes","family":"Sakji","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pharmacie Clinique, Centre Oscar Lambret, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Bonneterre","sequence":"additional","affiliation":[{"name":"D\u00e9partement Universitaire de Canc\u00e9rologie, UDSL, Universit\u00e9 de Lille Nord de France, Lille, France; D\u00e9partement de S\u00e9nologie, Centre Oscar Lambret, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Cazin","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pharmacie Clinique, Centre Oscar Lambret, Lille, France; Laboratoire de Pharmacologie et Pharmacie Clinique, Universit\u00e9 de Lille Nord de France, Lille, France; UDSL, Facult\u00e9 de Pharmacie, Lille, France,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2010,6,4]]},"reference":[{"key":"atypb1","unstructured":"Groves MD Leptomeningeal metastases: Still a challenge. ASCO Educational Book, Alexandria, VA: ASCO, 2008, p.80-87."},{"key":"atypb2","volume-title":"Information Alert System Alert","author":"World Health Organization.","year":"2007"},{"key":"atypb3","volume-title":"Recommandations destin\u00e9es \u00e0 pr\u00e9venir les risques d\u2019erreur d\u2019administration intrath\u00e9cale des vincaalcalo\u00efdes [Recommendations for Preventing the Risk of Error of Intrathecal Administration of Vinca-alcalo\u00efds]","author":"Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9.","year":"2007"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008731406552"},{"key":"atypb5","volume-title":"Survival of a cohort of 38 breast cancer patients with neoplastic meningitis treated with intrathecal liposomal cytarabine","author":"Le Rhun E.","year":"2009"},{"key":"atypb6","volume-title":"Risk Assessment of Spinal Procedures with Current Safeguards and with Proposed New Connector Design Options for the Department of Health","author":"National Patient Safety Agency.","year":"2004"},{"key":"atypb7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00005072-196810000-00007","volume":"27","author":"Schochet Jr SS","year":"1968","journal-title":"J Neuropathol Exp Neurol"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950050113"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.30.8.867"},{"key":"atypb10","first-page":"540","volume":"17","author":"Solimando DA","year":"1982","journal-title":"Hosp Pharm"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830901)52:5<799::AID-CNCR2820520508>3.0.CO;2-Z"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830601)51:11<2041::AID-CNCR2820511114>3.0.CO;2-G"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198911023211816"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199110000-00011"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950240114"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.3109\/15563659809028947"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199811000-00018"},{"key":"atypb18","volume-title":"Medication Safety Alert","author":"Institute for Safe Medication Practices.","year":"2000"},{"key":"atypb19","volume-title":"Medication Safety Alert","author":"Institute for Safe Medication Practices.","year":"2003"},{"key":"atypb20","volume-title":"Medication Safety Alert","author":"Institute for Safe Medication Practices.","year":"2003"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1007\/BF00313734"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.1080\/02724936.1992.11747596"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2002.108"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.1007\/s003810050338"},{"key":"atypb25","doi-asserted-by":"publisher","DOI":"10.1177\/002580249603600314"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.1999.14.6.688"},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3693183.x"},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.1007\/BF00314787"},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92052-4"},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7177.148"},{"key":"atypb31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7281.257"},{"key":"atypb32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7365.616"},{"key":"atypb33","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(01)00394-2"},{"key":"atypb34","doi-asserted-by":"publisher","DOI":"10.2515\/therapie:2007056"},{"key":"atypb35","doi-asserted-by":"publisher","DOI":"10.1081\/CLT-120014647"},{"key":"atypb36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2006.00241.x"},{"key":"atypb37","doi-asserted-by":"publisher","DOI":"10.3171\/spi.2007.6.3.280"},{"key":"atypb38","volume-title":"Rappel des recommandations visant \u00e0 pr\u00e9venir les risques d\u2019administration intrath\u00e9cale de vinca-alcalo\u00efdes. MED08\/B30","author":"Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9.","year":"2009"},{"key":"atypb39","unstructured":"The Sydney Morning Herald. Girl died after being given wrong drug. 1987; August 13: 5."},{"key":"atypb40","unstructured":"The Age. Victims pay the price of a lost lifestyle. 1995; November 11: 8."},{"key":"atypb41","first-page":"3","volume":"28","author":"Goebel F.","year":"2005","journal-title":"Vigilances"},{"key":"atypb42","volume-title":"National Guidance on the Safe Administration of Intrathecal Chemotherapy HSC 2001\/022","author":"Department of Health.","year":"2001"},{"key":"atypb43","volume-title":"Updated National Guidance on the Safe Administration of Intrathecal Chemotherapy HSC 2008\/001","author":"Department of Health.","year":"2008"},{"key":"atypb44","volume-title":"The Prevention of Intrathecal Medication Errors, A Report to the Chief Medical Officer","author":"Department of Health.","year":"2001"},{"key":"atypb45","volume-title":"Using Vinca Alkaloid Minibags (Adult\/Adolescent Units) Rapid Response Report 04","author":"National Patient Safety Agency.","year":"2008"},{"key":"atypb46","volume-title":"A Guide to using the Training Film","author":"Department of Health.","year":"2008"},{"key":"atypb47","volume-title":"Updated National Guidance on the Safe Administration of Intrathecal Chemotherapy HSC 2003\/010","author":"Department of Health.","year":"2009"},{"key":"atypb48","volume-title":"Preventing Vincristine Administration Errors","author":"The Joint Commission.","year":"2005"},{"key":"atypb49","volume-title":"IV Vincristine Survey shows Safety Improvements Needed","author":"Institute for Safe Medication Practices.","year":"2006"},{"key":"atypb50","volume-title":"Published Data Supports Dispensing Vincristine in Minibags as a System Safeguard","author":"Institute for Safe Medication Practices Canada.","year":"2001"},{"key":"atypb51","volume-title":"Errores asociados a la administraci\u00f3n de vincristina [Errors associated with the administration of vincristine]","author":"Institute for Safe Medication Practices Espana.","year":"2006"},{"key":"atypb52","volume-title":"Report on a Medication Incident of Intrathecal Administration of Vincristine in Prince of Wales Hospital","author":"Hospital Authority.","year":"2007"},{"key":"atypb53","volume-title":"Medication Alert. VINCRISTINE can be Fatal if Administered by the Intrathecal Route","author":"The Australian Council for Safety and Quality in Health Care.","year":"2005"},{"key":"atypb54","doi-asserted-by":"publisher","DOI":"10.1177\/001857870103600707"},{"key":"atypb55","doi-asserted-by":"publisher","DOI":"10.1177\/1078155206070448"},{"key":"atypb56","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2006.10.016"},{"key":"atypb57","volume-title":"The Development, Trial and Evaluation of a Safe Connector Design for Spinal and Epidural Devices","author":"National Patient Safety Agency.","year":"2008"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155210372550","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155210372550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:13:56Z","timestamp":1777688036000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155210372550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,4]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1177\/1078155210372550"],"URL":"https:\/\/doi.org\/10.1177\/1078155210372550","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,4]]}}}